Nasal stem cells for newborn brain injury to prevent cerebral palsy
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests giving stem cells through the nose to newborn babies who have brain injury from lack of oxygen or blood flow during birth. The goal is to reduce the risk of developing cerebral palsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be born at 35 weeks or later (full-term or near full-term).
- An MRI must show brain injury due to lack of oxygen or blood flow during birth.
- Your baby must have a confirmed diagnosis of PAIS (a type of stroke) or PA (perinatal asphyxia).
- Your baby must not have any known genetic disorders, metabolic conditions, or major birth defects of the brain.
- Your baby must not have nasal problems that would block the nose-drip medication.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at biomarkers (biological signs) in infants who had a brain injury around birth or were born very early, and compares them with healthy babies. The goal is to learn more about brain injuries and recovery.
This early-phase study tests whether using a baby’s own cord blood stem cells is safe and feasible for newborns with brain injury from lack of oxygen around birth. It may help researchers find new ways to treat hypoxic-ischemic encephalopathy (brain injury due to oxygen deprivation) in addition to standard care like cooling.
This trial tests whether giving stem cells along with cooling therapy is safe and helpful for babies who had brain injury from lack of oxygen at birth. It may help improve their recovery and development.
This trial tests whether a single infusion of stem cells from donated umbilical cord tissue can help calm inflammation in the brain after severe traumatic brain injury. It is for patients aged 18–50 who need brain pressure monitoring and are not responding to verbal commands 5 days after sedation is stopped.
This trial tests whether transplanting cells from a child's own bone marrow, combined with rehabilitation therapy, can improve movement and function in young children with cerebral palsy caused by birth-related brain injury or bleeding. The goal is to see if this approach helps children move better and become more independent.
This study looks at early brain scans and other markers to help predict and improve outcomes for newborns with brain injuries that might lead to cerebral palsy. It aims to find better ways to identify these high-risk babies early.
Hear when a new Perinatal Asphyxia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.